Cholesterol in patients with coronary heart disease: how low should we go? - Wikidata - awgldk - TriplyDB

Cholesterol in patients with coronary heart disease: how low should we go?

Cholesterol in patients with coronary heart disease: how low should we go?

http://www.wikidata.org/entity/Q40368068

about

Reduction in saturated fat intake for cardiovascular disease Reduced or modified dietary fat for preventing cardiovascular disease Reduced or modified dietary fat for preventing cardiovascular disease Reduced or modified dietary fat for prevention of cardiovascular disease.

P2860

Q24187203-EFF09E47-0390-40B4-AC4D-BCFB4DD4D9CE Q24197817-DAF8DAA0-7B2B-43BF-9571-C5A4E36733E7 Q24235559-9E53EA7D-0383-44C5-A2E8-68332E9E399E Q30868359-7DFCB7BA-665C-489F-AA36-D6C2CDF146B6

P2860

Cholesterol in patients with coronary heart disease: how low should we go?

http://www.wikidata.org/entity/Q40368068

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Cholesterol in patients with coronary heart disease: how low should we go?

@en

type

label

Cholesterol in patients with coronary heart disease: how low should we go?

@en

prefLabel

Cholesterol in patients with coronary heart disease: how low should we go?

@en

P1433

Q40368068-DB36721D-8CC3-4F1A-A168-FD6066F45FF9

P1476

Q40368068-90DD34B9-787C-4BDA-8B09-999EB733C7B4

P2093

Q40368068-F968CF43-2AAF-45D3-92C0-ACEFC7E5150C

P2860

Q40368068-0FB02323-23AC-486B-811B-12E5771A6047

Q40368068-23BC8489-D27C-4AEC-A5A8-27F5FF6591E4

Q40368068-86042C35-1437-45E3-A388-16B3F7D63CB5

Q40368068-9825F579-B4FA-4698-B22F-FF6046E215E5

Q40368068-AF73D732-0CAF-4F1D-B528-5A85423D991E

Q40368068-E18F4397-798C-4C7E-86F2-F0F7FD2A2B5B

Q40368068-EC073524-2F61-4502-B0C0-8A5390CE9D3A

P2888

Q40368068-0FAE74AE-7982-4FFF-B449-9F229B469996

P304

Q40368068-7B061545-BB06-4713-8460-A24B53A2BADA

P31

Q40368068-C30BB281-7A42-40E6-A82F-A4ADAD29E995

P356

Q40368068-7AC733E0-B6A1-4D9C-9F35-D1D4793428AF

P433

Q40368068-A650BD72-26E2-460F-B7FB-361D7E337FCD

P478

Q40368068-F6064CCD-774E-4928-BD97-03632F48DF58

P577

Q40368068-4235542E-72B0-4279-9748-04FD7CD5FF13

P6179

Q40368068-1AE1AB9A-4C2B-4017-AE30-392F1DDD8ABC

P698

Q40368068-81D282BA-4E63-4DCD-A50C-05C7A5D7F005

P356

P1433

Journal of General Internal Medicine

P1476

Cholesterol in patients with coronary heart disease: how low should we go?

@en

P2093

H B Rubins

http://www.w3.org/2001/XMLSchema#string

P2860

Cost and health implications of cholesterol lowering.

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

P2888

P304

464-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02599922

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

1995-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036921502

http://www.w3.org/2001/XMLSchema#string

P698

7472706

http://www.w3.org/2001/XMLSchema#string